Showing results (1221-1230 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|January 27, 2019
Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in ChinaYan Xu, Ningying Mao, Viktor Chirikov, et al.Clinical Drug Investigation|February 7, 2019
Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Jim Slattery, Alexandra Pacurariu, et al.Clinical Drug Investigation|February 11, 2020
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential FeaturesKatherine A Lyseng-WilliamsonClinical Drug Investigation|January 23, 2020
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind StudyHiroyuki Fukase, Toshifumi Kajioka, Ichiro Oikawa, et al.Clinical Drug Investigation|February 10, 2019
Bevacizumab Plus Direct Oral Anticoagulant Therapy in Ovarian Cancer Patients with Distal Deep Vein ThrombosisShinichi Komiyama, Masaru Nagashima, Tomoko Taniguchi, et al.Clinical Drug Investigation|March 5, 2020
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple SclerosisLorenzo G Mantovani, Paolo Cozzolino, Paolo A Cortesi, et al.Clinical Drug Investigation|March 21, 2020
Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series AnalysisDomenico Acanfora, Pietro Scicchitano, Chiara Acanfora, et al.Clinical Drug Investigation|March 8, 2020
Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based AnalysisJosep DarbàClinical Drug Investigation|November 30, 2019
Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its UseYvette N LambClinical Drug Investigation|January 20, 2019
Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational StudySermsiri Sangroongruangsri, Usa Chaikledkaew, Suthasinee Kumluang, et al.Pageof 234